Antimicrobial therapies are essential tools for transplant recipients who are at high risk for
infectious complications. However, judicious use of antimicrobials is critical to preventing the …

Abstract Objective Rising incidence of Clostridium difficile and multidrug‐resistant
organisms' infections and a dwindling development of new antimicrobials are an impetus for …

Antimicrobial stewardship is valuable to transplant programs to reduce the threat of
antimicrobial resistance, improve patient outcomes, and attenuate risks of drug toxicities. 1 …

Antimicrobial stewardship programs (ASPs) have made immense strides in optimizing
antibiotic, antifungal, and antiviral use in clinical settings. However, although ASPs are …

In the United States, antimicrobial stewardship programs (ASPs) are mandated by
government regulations and the Centers for Disease Control and Prevention has proposed …

Abstract Background Antibiotic stewardship programs (ASPs) are well established in the
public hospitals in Singapore, but they are not mandatory for transplant programs. Given the …

Background Solid organ transplant (SOT) recipients are challenging populations for
antimicrobial stewardship interventions due to a variety of reasons, including …

from each donor; range is 1 to 8 organs. It thus befits to start the current issue with an update
of this topic. In addition, several other articles in this issue address specific aspects of this …

Infectious complications are a major cause of morbidity and mortality in both solid organ and
hematopoietic stem cell transplant patients. The risk of infection by common opportunistic …

Background In the last decades, solid organ transplantation (SOT) has emerged as an
important method in the management of chronic kidney, liver, heart, and lung failure …